Cargando…

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data

OBJECTIVE: We aimed to examine the associations of obesity-related traits (body mass index [BMI], central obesity) and their genetic predisposition with the risk of developing severe COVID-19 in a population-based data. RESEARCH DESIGN AND METHODS: We analyzed data from 489,769 adults enrolled in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhaozhong, Hasegawa, Kohei, Ma, Baoshan, Fujiogi, Michimasa, Camargo, Carlos A., Liang, Liming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	COVID-19 in Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442576/ https://www.ncbi.nlm.nih.gov/pubmed/32835759 http://dx.doi.org/10.1016/j.metabol.2020.154345

Ejemplares similares

Association of asthma and its genetic predisposition with the risk of severe COVID-19
por: Zhu, Zhaozhong, et al.
Publicado: (2020)

Identifying and predicting severe bronchiolitis profiles at high risk for developing asthma: Analysis of three prospective cohorts
por: Fujiogi, Michimasa, et al.
Publicado: (2022)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

Obesity in patients with COVID-19: a systematic review and meta-analysis
por: Huang, Yi, et al.
Publicado: (2020)

Visceral fat is associated to the severity of COVID-19
por: Favre, Guillaume, et al.
Publicado: (2021)

Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()
por: Moin, Abu Saleh Md, et al.
Publicado: (2020)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Excess body weight is an independent risk factor for severe forms of COVID-19
por: Pietri, Léa, et al.
Publicado: (2021)

Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: Population-based, prospective cohort study
por: Hamer, Mark, et al.
Publicado: (2020)

Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study
por: Freuer, Dennis, et al.
Publicado: (2021)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Phospholipid remodeling and its derivatives are associated with COVID-19 severity
por: Wei, Juntong, et al.
Publicado: (2023)

Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
por: Yang, Jee Myung, et al.
Publicado: (2020)

Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
por: Abolhassani, Hassan, et al.
Publicado: (2022)

A population-based cohort study of sex and risk of severe outcomes in covid-19
por: Sieurin, Johanna, et al.
Publicado: (2022)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Association between smoking, e-cigarette use and severe COVID-19: a cohort study
por: Gao, Min, et al.
Publicado: (2022)

The association of obesity-related traits on COVID-19 severity and hospitalization is affected by socio-economic status: a multivariable Mendelian randomization study
por: Cabrera-Mendoza, Brenda, et al.
Publicado: (2022)

Integrated relationship of nasopharyngeal airway host response and microbiome associates with bronchiolitis severity
por: Fujiogi, Michimasa, et al.
Publicado: (2022)

Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study
por: Weber, Sabine, et al.
Publicado: (2021)

Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform
por: Wing, Kevin, et al.
Publicado: (2022)

Where did the patients go? Changes in acute appendicitis presentation and severity of illness during the coronavirus disease 2019 pandemic: A retrospective cohort study
por: Neufeld, Miriam Y., et al.
Publicado: (2021)

Metabolic impact of weight loss induced reduction of adipose ACE-2 – Potential implication in COVID-19 infections?
por: Li, Linna, et al.
Publicado: (2020)

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19
por: Watanabe, Mikiko, et al.
Publicado: (2020)

Commentary. Eliminating vitamin D deficiency during the COVID-19 pandemic: A call to action
por: Manson, JoAnn E., et al.
Publicado: (2020)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study()
por: Ghoneim, Sara, et al.
Publicado: (2020)

Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis
por: Du, Yanbin, et al.
Publicado: (2021)

Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic
por: Chakhtoura, M., et al.
Publicado: (2020)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

The serum metabolome of COVID-19 patients is distinctive and predictive
por: Shi, Ding, et al.
Publicado: (2021)

COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic
por: Tessier, Christopher M., et al.
Publicado: (2021)

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry
por: Spick, Matt, et al.
Publicado: (2022)

Drug repurposing in COVID-19: A review with past, present and future
por: Srivastava, Kamna, et al.
Publicado: (2021)

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19
por: Calvisi, Stefania L., et al.
Publicado: (2021)

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic()
por: Loh, Charlotte, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
por: Mathieu, Clément, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dpqbs3oo08d7vm0nur8h37m1p8